Cargando…
New Approaches to Dendritic Cell-Based Therapeutic Vaccines Against HIV-1 Infection
Due to the success of combined antiretroviral therapy (cART) in recent years, the pathological outcome of Human Immunodeficiency Virus type 1 (HIV-1) infection has improved substantially, achieving undetectable viral loads in most cases. Nevertheless, the presence of a viral reservoir formed by late...
Autores principales: | Espinar-Buitrago, Marisierra, Muñoz-Fernández, Ma Angeles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763680/ https://www.ncbi.nlm.nih.gov/pubmed/35058917 http://dx.doi.org/10.3389/fimmu.2021.719664 |
Ejemplares similares
-
Dendritic Cells, the Double Agent in the War Against HIV-1
por: Martín-Moreno, Alba, et al.
Publicado: (2019) -
Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals
por: Thiébaut, Rodolphe, et al.
Publicado: (2019) -
Nanoparticle-Delivered HIV Peptides to Dendritic Cells a Promising Approach to Generate a Therapeutic Vaccine
por: Martín-Moreno, Alba, et al.
Publicado: (2020) -
Dendritic Cell-Based Approaches in the Fight Against Diseases
por: Freitas-Silva, Rafael, et al.
Publicado: (2014) -
Trained Immunity-Based Vaccine in B Cell Hematological Malignancies With Recurrent Infections: A New Therapeutic Approach
por: Ochoa-Grullón, Juliana, et al.
Publicado: (2021)